SPIA
BSX icon

Steward Partners Investment Advisory’s Boston Scientific BSX Stock Holding History

Steward Partners Investment Advisory’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.8M Buy
60,573
+7,066
+13% +$565K 0.02% 612
2025
Q4 		$5.1M Sell
53,507
-1,132
-2% -$111K 0.03% 461
2025
Q3 		$5.33M Buy
54,639
+4,696
+9% +$486K 0.03% 453
2025
Q2 		$5.36M Sell
49,943
-159
-0.3% -$16.1K 0.04% 411
2025
Q1 		$5.05M Sell
50,102
-497
-1% -$50K 0.04% 394
2024
Q4 		$4.52M Buy
50,599
+433
+0.9% +$38.1K 0.04% 405
2024
Q3 		$4.2M Sell
50,166
-10,529
-17% -$830K 0.04% 409
2024
Q2 		$4.67M Buy
60,695
+1,595
+3% +$117K 0.05% 349
2024
Q1 		$4.05M Buy
59,100
+33,721
+133% +$2.17M 0.04% 380
2023
Q4 		$1.47M Buy
25,379
+4,127
+19% +$220K 0.02% 600
2023
Q3 		$1.12M Buy
21,252
+1,088
+5% +$57.1K 0.02% 640
2023
Q2 		$1.09M Sell
20,164
-5,256
-21% -$275K 0.02% 664
2023
Q1 		$1.27M Sell
25,420
-2,598
-9% -$122K 0.02% 613
2022
Q4 		$1.3M Buy
28,018
+1,447
+5% +$62.7K 0.02% 583
2022
Q3 		$1.03M Sell
26,571
-1,914
-7% -$76.8K 0.02% 617
2022
Q2 		$1.06M Buy
28,485
+41
+0.1% +$1.67K 0.02% 610
2022
Q1 		$1.26M Sell
28,444
-2,314
-8% -$100K 0.02% 620
2021
Q4 		$1.31M Buy
30,758
+534
+2% +$22.4K 0.02% 613
2021
Q3 		$1.31M Sell
30,224
-353
-1% -$15.6K 0.02% 578
2021
Q2 		$1.31M Sell
30,577
-9,222
-23% -$388K 0.02% 583
2021
Q1 		$1.54M Buy
39,799
+12,186
+44% +$461K 0.03% 506
2020
Q4 		$993K Buy
27,613
+10,322
+60% +$372K 0.02% 556
2020
Q3 		$661K Buy
17,291
+1,943
+13% +$74.9K 0.02% 593
2020
Q2 		$539K Buy
15,348
+3,856
+34% +$139K 0.02% 606
2020
Q1 		$374K Buy
11,492
+1,744
+18% +$68.1K 0.01% 632
2019
Q4 		$440K Buy
9,748
+287
+3% +$12K 0.01% 656
2019
Q3 		$384K Hold
9,461
– – 0.01% 658
2019
Q2 		$406K Sell
9,461
-2,583
-21% -$99.4K 0.01% 610
2019
Q1 		$462K Buy
12,044
+563
+5% +$21.5K 0.02% 538
2018
Q4 		$405K Sell
11,481
-56
-0.5% -$2.03K 0.02% 535
2018
Q3 		$444K Buy
11,537
+353
+3% +$12.3K 0.02% 532
2018
Q2 		$366K Sell
11,184
-1,103
-9% -$33.3K 0.02% 531
2018
Q1 		$335K Buy
12,287
+2,389
+24% +$64.9K 0.02% 502
2017
Q4 		$245K Buy
9,898
+5,100
+106% +$141K 0.02% 481
2017
Q3 		$139K Buy
4,798
+743
+18% +$20.5K 0.01% 492
2017
Q2 		$112K Buy
+4,055
New +$108K 0.01% 477

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Steward Partners Investment Advisory's BSX Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its Boston Scientific (BSX) stake by 13% in Q1 2026, buying an estimated $565K and bringing the position to 60,573 shares worth $3.8M. The position accounts for 0.02% of the portfolio, ranked #612.

Steward Partners Investment Advisory first reported a position in BSX in Q2 2017 and has held it in 36 quarters since. The position peaked at $5.36M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Steward Partners Investment Advisory held 60,573 shares of Boston Scientific worth $3.8M as of Q1 2026.
  • Steward Partners Investment Advisory bought 7,066 Boston Scientific shares in Q1 2026, an estimated $565K.
  • Boston Scientific made up 0.02% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #612 holding.
  • Steward Partners Investment Advisory first reported a position in Boston Scientific in Q2 2017 and has held it in 36 quarters since.
  • Steward Partners Investment Advisory's Boston Scientific position peaked at $5.36M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.